Underweight but metabolically abnormal phenotype: Metabolic features and its association with cardiovascular disease

Bixia Gao1, Luxia Zhang1, Minghui Zhao1

  • 1Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China; Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China.

Insights

Metabolically abnormal phenotypes are common in underweight Chinese adults and increase cardiovascular disease (CVD) risk. Preventive strategies for CVD should include underweight individuals with metabolic abnormalities.

Area of Science:

  • Cardiology
  • Metabolic Health
  • Public Health

Background:

  • Metabolic abnormalities are linked to cardiovascular disease (CVD) risk in normal and high body mass index (BMI) individuals.
  • Limited research exists on metabolic features and CVD association, especially in underweight populations.

Purpose of the Study:

  • To investigate the prevalence of metabolically abnormal phenotypes in underweight adults in China.
  • To examine the association between underweight, metabolic status, and the presence of CVD and albuminuria.

Main Methods:

  • Utilized a nationally representative sample of Chinese adults.
  • Defined underweight as BMI <18.5kg/m(2).
  • Classified participants as metabolically healthy (<2 metabolic syndrome criteria) or abnormal (≥2 criteria).

Main Results:

  • 4.6% of 46,308 participants were underweight, with 16.4% of them being metabolically abnormal.
  • Underweight, metabolically abnormal individuals showed higher odds of CVD (aOR 2.33) and albuminuria (aOR 2.56) compared to normal weight, metabolically healthy individuals.
  • Leisure inactivity, mild occupational activity, and waist circumference were associated with metabolic abnormality in underweight participants.

Conclusions:

  • Metabolically abnormal phenotypes are prevalent in the underweight Chinese population.
  • Underweight individuals with metabolic abnormalities face an elevated risk of CVD.
  • Preventive strategies for CVD should extend to metabolically abnormal underweight individuals.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.7K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
955
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
741
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.9K